A recent study by Woo et al. demonstrated the efficacy of combined checkpoint blockade using three distinct tumor types (B16 melanoma, MC38 colorectal adenocarcinoma, and Sa1N fibrosarcoma); in each of these tumors types, tolerized T cells were found to coexpress LAG-3 and PD-1. Here, PDCD1 is linked to fibrosarcoma.